𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Oncosurgical and reconstructive concepts in the treatment of soft tissue sarcomas: a retrospective analysis

✍ Scribed by Holger Bannasch; Irina Haivas; Arash Momeni; G. Björn Stark

Publisher
Springer
Year
2008
Tongue
English
Weight
382 KB
Volume
129
Category
Article
ISSN
1434-3916

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Docetaxel and gemcitabine combination in
Docetaxel and gemcitabine combination in 133 advanced soft-tissue sarcomas: A retrospective analysis
✍ Jacques-Olivier Bay; Isabelle Ray-Coquard; Jérôme Fayette; Serge Leyvraz; Stepha 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 165 KB

## Abstract Advanced soft‐tissue sarcomas are usually resistant to cytotoxic agents such as doxorubicin and ifosfamide. Antitumor activity has been observed for gemcitabine and docetaxel combination. We conducted a retrospective study on 133 patients (58 males/75 females) with unresectable or metas

Surgical treatment of pulmonary metastas
Surgical treatment of pulmonary metastases from soft tissue sarcomas: A retrospective study in the Netherlands
✍ Albert N. van Ceel; Frits Van Coevorden; Jan D. Blankensteijn; Harald J. Hoekstr 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 518 KB

## Abstract Sixty‐seven of 87 patients with soft tissue sarcoma underwent complete resection of the metastases in the lung. In this retrospective study, follow‐up was for a median of 24 months. The 5‐year overall, crude, and disease‐free survival was 38%, 45%, and 41%, respectively. Twentyseven (40

Soft tissue sarcomas of the popliteal fo
Soft tissue sarcomas of the popliteal fossa : A single-institution retrospective review
✍ Winston W. Huh; B. Ashleigh Guadagnolo; Mark F. Munsell; Shreyaskumar Patel; Val 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 218 KB 👁 1 views

## Abstract ## BACKGROUND: Soft tissue sarcomas (STSs) arising from the popliteal fossa present a challenge with regard to local control of primary tumors. Due to concerns of functional morbidity and neurovascular compromise, there is debate about what represents the best therapy for these patient